News

When bitcoin surged past $100,000 this month, many crypto skeptics felt a pang of something: Envy? Self-doubt? Resignation?

Money market account rates vary widely. So which banks are offering the best money market account rates today? Find out here.

A Chinese fund manager has touted its fund's cryptocurrency exposure in an effort to draw investors amid a historic bitcoin boom, even as Beijing maintains a hostile stance towards the digital assets. A fund advertisement that read "Cryptocurrencies soaring, start investing with 10 yuan" was spotted on Alipay, Chinese fintech giant Ant Group's mobile wallet app, crypto-focused outlet Wu Blockchain reported on Thursday. The fund, a Qualified Domestic Institutional Investor (QDII) fund operated by

Here is a 2-minute breakdown of everything important that happened in crypto today.

As of Thursday, the average target for the S&P 500 index to close at the end of 2025 was 6,678.18, which would be a 10% rise from the index's Thursday close.

Elon Musk says the Securities and Exchange Commission wants him to pay a penalty or face charges involving what he disclosed — or failed to disclose — about his purchases of Twitter stock before he bought the social media platform in 2022. In a letter posted by Musk on the platform now called X, his lawyer Alex Spiro tells the outgoing SEC chairman, Gary Gensler, that the commission's demand for a monetary payment is a “misguided scheme” that won't intimidate Musk. The letter also alleges that the commission reopened an investigation this week into Neuralink, Musk's computer-to-human brain interface company.

On Thursday, Repare Therapeutics Inc (NASDAQ:RPTX) revealed data from its MYTHIC Phase 1 gynecologic expansion trial evaluating the combination of lunresertib and camonsertib (Lunre+Camo) for endometrial cancer and platinum-resistant ovarian cancer (PROC) harboring lunre-sensitizing biomarkers. As of the data cut-off date of November 14, 51 evaluable patients were enrolled in the gynecologic cancer expansion cohort of the MYTHIC trial. Across all tumor types treated at the optimized RP2D (n=67),

JP Morgan analyst Christopher Horvers reiterated the Overweight rating on Costco Wholesale Corporation (NASDAQ:COST) with a price forecast of $1,090. The analyst suggests that the ongoing global momentum in the business, share gains across various sectors and geographies (including e-commerce growth), and the company’s leverage to a cyclical upswing in big-ticket items (about 20% of the comp) contribute to its strong performance. Additionally, the emerging benefits from advertising revenue make

Broadcom shares rocketed higher Friday, a day after the company’s fiscal fourth-quarter results topped expectations, leading several analysts to raise their price targets.

Malaysia's palm oil production is set to fall for the fourth consecutive month in December as heavy rainfall hit harvesting in the world's second-largest producer of the tropical oil, the industry regulator told Reuters on Friday. Lower output in Malaysia would curb inventories in the country and further boost benchmark futures, which are already near their highest levels in about 2-1/2 years. "We estimate a potential reduction of around 5% to 8% in crude palm oil (CPO) production under normal circumstances," Ahmad Parveez Ghulam Kadir, director-general at the Malaysian Palm Oil Board (MPOB) said.